D20.215.894.899.085

3 trials

Sponsors

Fundação Oswaldo Cruz, Centro de Tecnologia em Vacinas (CT Vacinas) da Universidade Federal de Minas Gerais, Janssen Vaccines & Prevention B.V

Conditions

Immunogenicity, VaccineRNA Virus InfectionsVaccine Immunogenicity

Phase 1

A study to evaluate innate and pro-inflammatory responses of an Ad26-based SARS-CoV-2 vaccine, an Ad26-based RSV vaccine, and an Ad26-based Ebola virus vaccine in adults aged 18 to 59 years

Active, not recruitingRBR-4dk4rss

Janssen Vaccines & Prevention B.VVaccine Immunogenicity

Start: 2022-11-03Updated: 2025-10-27

Phase 2

Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG

RecruitingRBR-3f598cj

Centro de Tecnologia em Vacinas (CT Vacinas) da Universidade Federal de Minas GeraisImmunogenicity, Vaccine

Start: 2022-11-23Updated: 2025-10-27

Unknown Phase

Evaluation of the humoral response to COVID-19 vaccines in Brazil

RecruitingRBR-33ndb47

Fundação Oswaldo CruzRNA Virus Infections

Start: 2021-02-25Updated: 2025-10-27